Intellia Therapeutics NTLA Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's total liabilities & equity?
- Intellia Therapeutics (NTLA) reported total liabilities & equity of $758.78M in Q1 2026.
- How has Intellia Therapeutics's total liabilities & equity changed year-over-year?
- Intellia Therapeutics's total liabilities & equity decreased by 23.1% year-over-year, from $986.16M to $758.78M.
- What is the long-term trend for Intellia Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), Intellia Therapeutics's total liabilities & equity has grown at a 4.5% compound annual growth rate (CAGR), from $676.32M to $842.13M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.